Biontech investor calendar

Web2 days ago · BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific … WebAug 8, 2024 · On today's stock market, BNTX stock crumbled 7.5% and closed at 169.30. BioNTech reiterated its guidance for 13 billion to 17 billion euros in full-year Covid vaccine sales. That translates to ...

BioNTech

WebMay 9, 2024 · At the beginning of April 2024, BioNTech published its second ESG report (Sustainability Report 2024), which can be found in the Investor Relations section of … WebMar 13, 2024 · 02.28.2024. Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older … small saphenous vein location https://mbsells.com

These early BioNTech investors just saw their faith rewarded with a ...

WebJan 11, 2024 · BioNTech SE said its revenue from the Covid-19 shot it sells together with Pfizer Inc. may be lower this year than last, predicting sales between 13 billion euros and … WebApr 11, 2024 · 13 analysts have issued twelve-month price targets for BioNTech's shares. Their BNTX share price forecasts range from $130.00 to $260.00. On average, they anticipate the company's share price to reach $178.50 in the next twelve months. This suggests a possible upside of 38.5% from the stock's current price. WebMar 18, 2024 · For their portion of the partnership, Fosun paid $50 million to purchase 1.58 million BioNTech shares, and will provide $85 million for development and commercialization fees. highonm

Press Release - Investors & Media BioNTech

Category:BioNTech - Funding, Financials, Valuation & Investors - CrunchBase

Tags:Biontech investor calendar

Biontech investor calendar

BNTX BioNTech SE ADR Stock Price & News - WSJ

WebJan 29, 2024 · Let's examine three things that smart investors are likely to understand about this stock. Image source: Getty Images. 1. Comirnaty will need to keep evolving. BioNTech's only product on the ... WebApr 6, 2024 · Earnings Summary. For their last quarter, BioNTech (BNTX) reported earnings of $9.46 per share, beating the Zacks Consensus Estimate of $8.04 per share. …

Biontech investor calendar

Did you know?

WebNov 30, 2024 · BioNTech: Media Relations Jasmina Alatovic +49 6131 9084 1513 [email protected]. Investor Relations Sylke Maas, Ph.D. +49 6131 9084 1074 [email protected]. Ryvu Therapeutics: Investors Contact: John Fraunces LifeSci Advisors +1 917-355-2395 [email protected]. Media Contact: Natalia … Web1 day ago · BIONTECH SE company earnings calendar and analyst expectations - Upcoming and past events Bolsa de Valores de Sao Paulo: B1NT34 Bolsa de Valores …

WebMay 12, 2024 · Participants may also access the slides and the webcast of the conference call via the “Events & Presentations” page of the Investor Relations section of the … WebSep 18, 2024 · In other words, as many stocks worldwide were hitting 52-week low in mid-March, BioNTech investors were jubilant. Yet in a matter of weeks, the shares were …

WebJun 5, 2024 · Calendars. Trending Tickers. Stocks: Most Actives. Stocks: Gainers. Stocks: Losers. Top ETFs. ... E-mail: [email protected]. Media Relations Jasmina Alatovic VP Corporate Communications Tel ... WebAug 9, 2024 · BioNTech stock analysts called for the company to earn $33.12 a share on $14.68 billion in sales for the year. BioNTech stock has a perfect Relative Strength Rating of 99, according to IBD Digital ...

WebMar 23, 2024 · Every investor in BioNTech SE (NASDAQ:BNTX) should be aware of the most powerful shareholder groups. We can see that private equity firms own the lion's share in the company with 43% ownership.

WebMar 14, 2024 · Welcome to our investor page. Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company … Financial Calendar; Corporate Governance. Corporate Governance. Overview; ... Financial Calendar; Corporate Governance. Corporate Governance. Overview; ... BioNTech's Annual General Meeting was held on June 1, 2024, online, without … highonthoughts.comWebOct 9, 2024 · Funding. BioNTech has raised a total of $1.7B in funding over 9 rounds. Their latest funding was raised on Apr 14, 2024 from a Post-IPO Equity round. BioNTech is … highonrankWebNov 13, 2024 · All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law. CONTACTS. Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 [email protected]. Investor Relations Sylke Maas, PhD. +49 (0)6131 9084 1074 … small saphenous vein thrombosis symptomsWebFeb 4, 2024 · BioNTech’s largest shareholders are biotech investors Thomas and Andreas Struengmann, who hold about half of the company’s shares between them. ($1 = 0.8341 euros) Reporting by Ludwig Burger ... small sapphire tibiaWebNov 7, 2024 · BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on November 7, 2024 at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial results and provide a corporate update for the third quarter of 2024. To access the live conference call via telephone, please register via this link. highonstyl fashionWebApr 10, 2024 · BIONTECH SE company earnings calendar and analyst expectations - Upcoming and past events Nasdaq: BNTX Nasdaq small saphenous vein phlebitisWeb1 day ago · BIONTECH SE company earnings calendar and analyst expectations - Upcoming and past events Bolsa de Valores de Sao Paulo: B1NT34 Bolsa de Valores de Sao Paulo ... Top Investor Rating. Top Trading Rating. Top Consensus. Low valuations. My Screeners. All my stocks. ... Past sector events for BIONTECH SE: 03/29/23 : BEIGENE, … highonu1